Gian Paolo Visentin - Concepedia

Author

Gian Paolo Visentin

Also Known As

G P Visentin, G VISENTIN, G Visentin, G. P. Visentin, G. Visentin, G.P. Visentin, Gian P Visentin, Gian P. Visentin, Gian Paolo Visentin, Gian Visentin

Publications

2.1K

Citations

H-Index

Concepts

All Affiliations

Versiti Blood Center of Wisconsin Medical College of Wisconsin Inserm Institut Gustave Roussy Hôpital Avicenne

About

Gian Paolo Visentin is an author at Versiti Blood Center of Wisconsin specializing in medicine, immunology, and hematology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	7	7	692
2	Immunology	6	6	519
3	Cell Biology	2	2	141
4	Health Sciences	1	1	68
5	Medical Laboratory Science	1	1	68

Gian Paolo Visentin

Publications

1.8K

Citations

H-Index

Page 1

	Year	Citations
Antibodies from patients with heparin-induced thrombocytopenia/thrombosis are specific for platelet factor 4 complexed with heparin or bound to endothelial cells. Gian Paolo Visentin, S E Ford, James G. Scott, Journal of Clinical Investigation	1994	553
Patients treated with unfractionated heparin during open heart surgery are at high risk to form antibodies reactive with heparin:platelet factor 4 complexes Gian Paolo Visentin, Mohammad Malik, K.A. Cyganiak, Journal of Laboratory and Clinical Medicine ThrombopoiesisThrombosisCardiovascular DiseaseBlood PlateletUnfractionated Heparin	1996	173
Platelet Factor 4 Differentially Modulates CD4+CD25+ (Regulatory) versus CD4+CD25− (Nonregulatory) T Cells Chao Yan Liu, Manuela Battaglia, Seon Ho Lee, The Journal of Immunology	2005	136
Heparin is not required for detection of antibodies associated with heparin-induced thrombocytopenia/thrombosis Gian Paolo Visentin, Michael Moghaddam, Sheila E. Beery, Journal of Laboratory and Clinical Medicine ThrombopoiesisThrombosisVenous ThrombosisAutoimmune DiseaseBlood Platelet	2001	131
Cytolytic function and survival of natural killer cells are severely altered in myelodysplastic syndromes Jean‐Jacques Kiladjian, E. Bourgeois, Ida Lobe, Leukemia Hematological MalignancyBone Marrow FailureCytolytic FunctionMalignant Blood DisorderHematology	2006	122
Characterization of the humoral immune response in heparin-induced thrombocytopenia Jang Soo Suh, Mohammad Malik, Richard H. Aster, American Journal of Hematology ThrombopoiesisThrombosisHigher TiterAutoimmune DiseaseBlood Platelet	1997	119
Antibodies From Patients With Heparin-Induced Thrombocytopenia/Thrombosis Recognize Different Epitopes on Heparin: Platelet Factor 4 Jang Soo Suh, Richard H. Aster, Gian Paolo Visentin Blood	1998	105
Immune complexes formed following the binding of anti–platelet factor 4 (CXCL4) antibodies to CXCL4 stimulate human neutrophil activation and cell adhesion Zhihua Xiao, Gian Paolo Visentin, Kannayakanahalli M. Dayananda, Blood	2008	87
Inhibition of Human Umbilical Vein Endothelial Cell Proliferation by the CXC Chemokine, Platelet Factor 4 (PF4), Is Associated With Impaired Downregulation of p21Cip1/WAF1 G. Gentilini, Nancy E. Kirschbaum, James A. Augustine, Blood	1999	79
Detection of drug‐dependent, platelet‐reactive antibodies by antigen‐ capture ELISA and flow cytometry Gian Paolo Visentin, K. W. Wolfmeyer, PJ Newman, Transfusion ImmunohematologyImmunologyImmunophenotypingAntigen‐ Capture ElisaPharmacotherapy	1990	68

Page 1